Kidney transplant recipients with hepatitis C virus experienced 100% sustained virologic response at 12 weeks when treated with sofosbuvir-ledipasvir.
about
Kidney transplant recipients with hepatitis C virus experienced 100% sustained virologic response at 12 weeks when treated with sofosbuvir-ledipasvir.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Kidney transplant recipients w ...... ed with sofosbuvir-ledipasvir.
@en
type
label
Kidney transplant recipients w ...... ed with sofosbuvir-ledipasvir.
@en
prefLabel
Kidney transplant recipients w ...... ed with sofosbuvir-ledipasvir.
@en
P2860
P356
P1433
P1476
Kidney transplant recipients w ...... ed with sofosbuvir-ledipasvir.
@en
P2093
Meghan E Sise
P2860
P356
10.1002/HEP.29339
P407
P577
2017-06-26T00:00:00Z